Generics giant in the making, Bangladesh leveraged policy foresight and WHO-GMP certified manufacturing excellence to export affordable essential medicines worth over $200 million reaching 115+ countries already! With almost 65% technical workforce comprising motivated women gaining skills through localized training programs, industry competitively meets international quality compliance producing medicines integral for domestic access too.
Yet complacency has no room with global competition heating up across complex biosimilars and vaccines production domains which Bangladesh eyes leveraging next through deeper R&D prioritization. This necessitates coordinated efforts between industry captains, academicians and regulatory authorities to attract joint investments, foster IP exchanges and align product development with international standards through appropriate mentoring.
As emerging markets specialists assisting pharmaceutical enterprises refine strategic planning earlier, consulting firm RFC brings proven advisory solutions spanning regulatory approvals assignment, digital supply chain development frameworks, international partnerships leverage and innovation roadmapping to help Bangladesh consolidate export leadership sustainably while keeping quality healthcare affordable back home! Well, together let’s notch higher success all around!